Skip to content

Clinical trials

Fibrosis trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fibrosis Phase: Not applicable Clear all

340 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20021
20042
20057
20067
20077
20084
20096
201010
201113
20129
201314
201413
201513
201620
201728
201818
201916
202013
202122
202221
202317
202422
202520
202628

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed174
Unknown status55
Recruiting54
Not yet recruiting18
Terminated17
Withdrawn9
Active, not recruiting8
Enrolling by invitation3
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institute of Liver and Biliary Sciences, India18
Assistance Publique - Hôpitaux de Paris12
Northern Jiangsu People's Hospital12
Hospices Civils de Lyon8
University of Michigan8
Massachusetts General Hospital7
Seoul National University Hospital6
University of Pennsylvania6
Govind Ballabh Pant Hospital5
Hunter Holmes Mcguire Veteran Affairs Medical Center5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fibrosis340
Liver Cirrhosis44
Hypertension, Portal38
Carcinoma, Hepatocellular27
Ascites18
Hepatic Encephalopathy17
Liver Diseases16
Non-alcoholic Fatty Liver Disease16
End Stage Liver Disease13
Sarcopenia13

Trials

Showing 51 to 75 of 340. Each trial links to its page on Pharma Observatory.

240 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.